Article citationsMore>>

Freeman, D., Lambe, S., Kabir, T., Petit, A., Rosebrock, L., Yu, L., et al. (2022) Automated Virtual Reality Therapy to Treat Agoraphobic Avoidance and Distress in Patients with Psychosis (Gamechange): A Multicentre, Parallel-Group, Single-Blind, Randomised, Controlled Trial in England with Mediation and Moderation Analyses. The Lancet Psychiatry, 9, 375-388.
https://doi.org/10.1016/s2215-0366(22)00060-8

has been cited by the following article:

• TITLE: Exploring the Role of Virtual Reality and Metaverse in Treating Mental Health: Operating Models and Challenges in Adoption

  AUTHORS: Simrat Rajpal

  KEYWORDS: Virtual Reality (VR), Metaverse, Cognitive Behavioral Therapy (CBT), Post-Traumatic Stress Disorder (PTSD), Immersive Therapy, Clinical Validation, Data Privacy

  JOURNAL NAME: Journal of Computer and Communications, Vol.13 No.10, October 10, 2025

  ABSTRACT: The advent of virtual reality (VR) has introduced new avenues for treating mental health conditions such as post-traumatic stress disorder (PTSD), anxiety, and depression. These conditions have traditionally been managed with pharmacological and psychotherapeutic treatments. However, these treatments often present issues such as medicinal side effects, accessibility barriers like high cost, and geographical constraints. This study explores the potential of VR and metaverse to offer more accessible and engaging treatment alternatives. By analyzing the service models of XRHealth, Innerworld, and PsyTechVR, we aim to critically evaluate the efficacy of these technologies in mental health treatments and analyze associated challenges including accessibility, side effects, privacy, and security concerns. The findings aim to contribute to the ongoing discussion on digital health innovations and prescription digital therapy by providing a comprehensive analysis of cutting-edge virtual reality and metaverse technologies in overcoming traditional treatment barriers in treating mental health.